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RETICULUM STRESS, AND MITOCHONDRIAL
DYSFUNCTION
Bi-Yu Liu1, Yuh-Ju Lee2, Hsian-Chin Jen3, and Deng-Fwu Hwang2
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ABSTRACT
Aluminum (Al) is one of the most abundant elements on the
earth’s crust and is used in various industrial applications. However, Al is known to be associated with various neurodegenerative
diseases. Taurine is a free amino acid presents at high concentrations in the brain and is crucial for neuron development. Here,
the protective effects of taurine against Al-induced neurotoxicity
were investigated. Al, at a concentration of 600 M, induced apoptosis of and cell cycle arrest in human neuroblastoma SH-SY5Y
cells. Additionally, Al induced a 55% increase in the levels of
reactive oxygen species and inhibited mitochondrial membrane
potential up to 60%. Al treatment also stimulated caspase 9
activities and Grp78 production. Furthermore, the expressions
of neurotrophic genes including NDRG-4, BDNF and SIRT1
were inhibited. Hence this study revealed that taurine attenuates
oxidative stress, ER stress and mitochondrial dysfunction and
consequently protects against Al-induced cytotoxicity and neuronal apoptosis.

I. INTRODUCTION
Aluminum (Al) is a ubiquitous element encompassing approximately 8.3% of earth’s crust, and is abundantly distributed in
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the environment as an industrial toxicant. Al has been applied
in daily life in medicine, food processing, agriculture and water
treatment (Bertholf et al., 1989; Becariaet al., 2002; Donmez
et al., 2010). Al pollution disrupts the homeostasis of several
metals, including magnesium, calcium and iron, and thereby inducing Al toxicity which affects biological functions and triggers many biochemical alterations (Hansen et al., 2010). These
influences cause renal failure and systemic toxicity in various
tissues including the brain, bone, liver and kidney. Epidemiological studies have provided evidence of the relationship between
high Al levels and increased risk of numerous neurodegenerative
disorders including Alzheimer’s disease (AD) and Parkinson’s
disease (PD) (Berthon, 1996; Chen et al., Becaria et al., 2002;
Yokel, 2002; Yumoto et al., 2009; Chen et al., 2011; Chou et al.,
2013; Wasi et al., 2013).
1. Al Induces Neurodegenerative Diseases
Al reportedly causes an overproduction of reactive oxygen
species (ROS) which can induce mitochondrial DNA mutation,
mitochondrial respiratory chain damage, and membrane permeability alteration as well as influence calcium homeostasis and
mitochondrial defense systems to cause apoptosis. Furthermore,
ROS was also reported to affect endoplasmic reticulum (ER) stress
via activation of caspase-12, thereby causing cell death (Perl
and Moalem, 2006). Based on these studies, the role of Al has
been implicated in neurodegenerative diseases (Kumar and Gill,
2009). AD is characterized by neuropathological hallmarks,
namely Tau/neurofibrillary tangle and amyloid- (beta)/amyloid
plaques, which are accompanied by synaptic and neuronal loss
as well as astrocytic gliosis (Tang and Chua, 2008). Additionally,
this disease induces progressive loss of memory and cognitive
dysfunction.
2. Al causes Neuronal Cell Apoptosis
Moreover, neurotrophic factors (NTFS) such as the N-myc
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downstream regulated gene (NDRG), brain-derived neurotrophic
factor (BDNF) and sirtuin-1 (SIRT-1) are small, versatile proteins that maintain neuronal cell survival and function. NDRG
family consists of four related proteins. NDRG-1~3 proteins
are expressed in human umbilical vein endothelial cells, cortical
pyramidal neurons and outer layers of the seminiferous epithelium,
respectively (Schilling et al., 2009; Kawahara and Kato-Negishi,
2011; Yamanoto et al., 2011), whereas NDRG-4 is expressed
in the brain and heart. Especially, NDRG-4 is a stress-related
protein, which protects cells against neurological disorders and
cerebrovascular disease. Notably, BDNF and SIRT-1 play an
important role in cognition, learning and memory formation by
modulating synaptic plasticity (Takahashi et al., 2005). An In
vivo study revealed that BDNF level is decreased in the brain
of NDGR-4 deficient mice. Similarly, this phenomenon is also
observed in AD patients (Takahashi et al., 2005; Pan et al., 2010).
Additionally, SIRT-1 promotes mitochondria biogenesis and
regulates survival-related genes in neuronal cells. Indeed, the
over-expression of SIRT-1 attenuates -amyloid production in
an AD mouse model (Das et al., 2009; Song et al., 2012).
3. Taurine Plays a Protective Role by Preventing Al-Insult
Taurine (2-aminoethane sulfonic acid), a nonprotein amino
acid exists in a variety of organs in mammals and is present at
high concentration (5% in dried weight) in seafood, especially
squid and mussel. On the other hand, the concentration of taurine
in the mature central nervous system (CNS), immature CNS, and
embryonic neocortex was reportedly 25 M, 75 M and 1 mM,
respectively (Benitez-Diaz et al., 2003; Molchanova et al., 2004;
Furukawa et al., 2014). Various experimental studies have shown
that taurine is an essential neuromodulator that plays a role in
neuronal development via gamma-aminobutyric acid (GABA)
and glutamate neurotransmitters (Kilb and Fukuda, 2017). GABAA
receptors showed a rather low taurine affinity above an EC50
value of 10 mM (Kibl and Fukuda, 2017). In vivo studies have
revealed that taurine has inhibitory effects on the mature CNS,
including anticonvulsive and antinociceptive effects, and also
plays a role in memory formation (El Idrissi and L’Amoreaux,
2008; Hara et al., 2012; Neuwirth et al., 2013). In vitro studies
showed that 25 mM taurine has neuroprotective effects on
arsenic-induced neurotoxicity by reducing ER stress and glutamate excitotoxicity (Pan et al., 2010; Chou et al., 2013; Prentice
et al., 2017). Hansen et al. (2010) reported that the taurine level
in the mitochondria of a rat heart is approxiunately 25 mM.
Several studies in recent years have suggested that taurine protects against oxidative stress, neurotoxicity and hepatic steatosis
(Idrissi and Trenkner, 1999; Das et al., 2009; Kumar and Gill,
2009; Chen et al., 2011). Moreover, taurine treatment reduces
hepatic lipids in chronically ethanol-treated rats and increases
SIRT-1 level in zebra fish and also has a preventive function
against atherosclerotic diseases, hyperlipidemia, and hepatic necrosis (Kokame et al., 1996; Corain et al., 1996; Kerai et al.,
1999; Balkan et al., 2002).
Based on the above mentioned reports, it can be elucidated
that Al induces oxidative stress and causes neurodegenerative
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diseases, but taurine has protective effect against neurotoxicity.
However, the protective mechanism of taurine still remains
controversial. Here, aluminum maltolate, Al(mal)3, was used to
induce neuronal cell apoptosis and the protective mechanism
of taurine was investigated.

II. MATERIALS AND METHODS
1. Chemicals
DEME/F12 medium and trypsin-EDTA were purchased from
Gibco (Carlsbad, CA, USA). Fetal bovine serum was purchased
from Hyclone Laboratories, Inc. (Logan, UT, USA). The purelinkTM RNA mini kit was purchased from Invitrogen (Carlsbsd,
CA, USA). Taurine, aluminum chloride hexahydrate, maltol,
hydrogen peroxide, 2,7-dichlorofluorescin diacetate (DCFDA),
rhodamine 123, ribonclease A (RNase A) and propidium iodide
(PI) were purchased from Sigma (St. Louis, MO, USA). A
HiScrip ITM first-strand cDNA synthesis kit system was purchased from Bionovas Biotechnology (Toronto, Ontario, Canada).
Annexin V-FITC was purchased from affymetrix eBioscience
(Mountain View, CA, USA). Oligo (dT) 15 primer was purchased
from Promega (Madison, WI, USA). The iQ SYBER Green
Supermix was purchased from Bio-Rad (Hercules, CA, USA).
Primers in the study were purchased from Mission Biotech
(Taipei, Taiwan). Other chemicals used in the study were of cell
culture grade and were purchased from common sources.
2. Preparation of Aluminum Maltolate
Aluminum maltolate, or Al(mal)3, was prepared from aluminum chloride hexahydrate (AlCl3  6H2O) and maltol according
to the method described by Bertholf et al. (1989). The stock
solutions of AlCl3  6H2O (40.9 mM) and maltol (122.8 mM)
were dissolved in distilled water and accompanied by mild heating to facilitate dissolution. Briefly, the pH was adjusted to 8.3
and the mixture was set at 65C. After cooling, the off-white
crystals obtained were filtered, washed several times by acetone,
and dried overnight in an oven (Perl and Moalem, 2006).
3. Cell Culture and Experimental Setup
The human neuroblastoma SH-SY5Y cell line was obtained
from the American Type Culture Collection (ATCC) (Manassas,
VA, USA); the cll line was incubated with DMEM/F12 (1:1 ratio)
medium supplemented with 10% fetal bovine serum, antibiotics
(100 U/mL penicillin and 100 g/mL streptomycin), 2 mM Lglutamine, 1 mM sodium pyruvate and 0.1 mM nonessential
amino acids in a 75 cm2 flask, and maintained in a humidified
incubator with 5% CO2 at 37C. The experiment was assigned
as four groups, including control group, taurine group, Al group,
and taurine  Al group. Control group: The cells were cultured
in the medium; Taurine group: The cells were cultured in the
medium supplemented with 25 mM taurine; Al group: The cells
were cultured in the medium supplemented with 600 M Al (mal)3;
and taurine  Al group: The cells were cultured in the medium
supplemented with 25 mM taurine and 600 M Al (mal)3.

66

Journal of Marine Science and Technology, Vol. 27, No. 1 (2019 )

4. Determination of Cell Viability
Cell viability was examined using Annexin V-FITC agent
via flow cytometry ((Phillips et al., 1991). A total of 8  105
cells were seeded into a 6-well plate. The next day, the medium
was removed and fresh medium with or without 600 M Al(mal)3
and 25 mM taurine was added and maintained for 24 h. After
the incubation period, 5 l Annexin V-FITC solution was added
to the wells containing 100 L medium, and the plate was incubated at 37C for 30 min. After the incubation period, the cell
pellet was washed with PBS and analyzed on a Becton-Dickinson
FACScan using the CellQuest software. The quantitative results
of fluorescence analysis were presented as mean value of three
independent experiments.
5. Determination of Cell Cycle
Cell cycle was examined by PI staining (Rizvi et al., 2014).
A total of 8  105 cells were seeded into a 6-well plate. On the
next day, the medium was removed and fresh medium was added
with or without 25 mM taurine and 600 μM Al(mal)3 and further maintained for 24 h. After the incubation period, cells were
fixed in 70% alcohol at -20C overnight. Cells were stained
with 500 LPI solution (50 g/mL PI, 0.1 mg/mL RNase A, 0.05%
Triton X-100) for 40 min to facilitate selection of the viable cell
population at 37C. After the incubation period, the cell pellet
was washed with PBS and analyzed on a Becton-Dickinson
FACScan flow cytometer, which employed the CellQuest software.
6. Determination of Intracellular ROS
Intracellular oxidative stress was estimated with 2,7dichlorofluorescin diacetate fluorescence using inverted fluorescence microscopy and flow cytometry. DCFDA was converted
to fluorescent DCH by peroxides and thereby lost its cellpermeant ability and was retained inside cells (Phillips et al.,
1991). A total of 8  105 cells were seeded into a 6-well plate. On
the next day, the medium was removed and fresh medium was
added with or without 25 mM taurine and 600 M Al(mal)3,
which was further maintained for 24 h. Cells were incubated
with 10 M DCFDA in serum-free DMEM-F12 medium at 37C
for 30 min. After the staining period, medium was removed and
cells were washed with ice-cold PBS. Sebsequently, cells were
observed through inverted fluorescence microscope (Nikon,
Japan) and analyzed on a Becton-Dickinson FACScan flow cytometer, which employed the CellQuest software.
7. Determination of MMP
MMP was determined using fluorescent rhodamine 123 (Rizvi
et al., 2014). Briefly, a total of 8  105 cells were incubated with
or without Al(malt)3 and taurine overnight. After 24 h, the medium was removed and the cells were stained with 10 μM rhodamine 123 at 37C for 30 min. Then, the cells were harvested
with 0.25% trypsin and analyzed on a Becton-Dickinson FACScan
flow cytometer, which employed the CellQuest software.
8. Quantitative Real-Time PCR
Gene expression was examined via quantitative real-time PCR

Table 1. The sequences of the primers used in this study.
Primers
NDRG-4-forward
NDRG-4-reverse
BDNF-forward
BDNF-reverse
SIRT-1-forward
SIRT-1-reverse
B2M-forward
B2M-reverse

Sequences
5-GGAGGTTGTCTCTTTGGTCAAGGT-3
5-CTCATGACAGCAGCCACCAGAAT-3
5-AAACATCCGAGGACAAGGTG-3
5-AGAAGAGGAGGCTCCAAAGG-3
5-TGCTGGCCTAATAGAGTGGCA-3
5-CTCAGCGCCATGGAAAATGT-3
5-GAGGTTTGAAGATGCCGCATT-3
5-TGTGGAGCAACCTGCTCAGATA-3

(Phillips et al., 1991). Total RNA was extracted using the purelinkTM RNA mini kit, and 1 g RNA was used for cDNA synthesis using the Hiscrip Itm first-strand cDNA synthesis kit
system for quantitative real-time PCR (qPCR). The qPCR of
NDRG-4, BDNF, SIRT-1 and -2-microglobulin (B2M) genes
was carried out using the iQ SYBR Green Supermix system
(Bio-Rad, USA). The gene expression results of NDRG-4, BDNF
and SIRT-1 were normalized by B2M levels. The sequences of
primers are shown in Table 1.
9. Western Blotting
After the experimental period, cells were lysed in radioimmunoprecipitation assay buffer containing 1% (v/v) protease
inhibitor cocktail on ice for 15 min. After centrifugation (20,800
g) for 10 min, the supernatant is collected protein extraction. The
protein was separated by sodium dodecyl sulfate polyacrylamide
gel electrophoresis and transferred to a polyvinylidene difluoride
membrane (Pan et al., 2010). Subsequently, the membrane was
blocked by its placement in Tris buffer saline (pH 7.5) containing 0.1% tween-20 (TBST) and 5% defatted milk powder for 2 h
at room temperature. Then, the membrane was washed twice
with TBST and incubated with a corresponding primary antibody (1:500) overnight and an HRP-conjugated secondary antibody (1:5,000) at room temperature for 2 h. Finally, the membrane
was washed with TBST twice and visualized using an electrochemiluminescence kit in an imaging system. The band area
is quantified by Quantity One software and considered as the
amount of expressed Grp78. The quantitative results were presented as mean values of three independent experiments.
10. Statistical Analysis
The results were represented as mean  SEM values of four
independent experiments and statistically analyzed by ANOVA
followed by the Tukey test. A P value of < 0.05 value was considered statistically significant.

III. RESULTS
1. Effect of Taurine on Cell Cytotoxicity Induced by
Al(mal)3 Treatment of SH-SY5Y Cells
Fig. 1 shows the effect of 600 M Al(mal)3 on cell viability
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Fig. 1. Al-induced apoptosis and the protective effect of taurine on human neuroblastoma SH-SY5Y cells. Cells were treated with or without Al 600
μM Al and 25 mM taurine for 24 h. (a) Apoptosis is examined by flow cytometry. (b) The quantitative data are represented as the mean ± SEM
values of four independent experiments.
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Fig. 2. Al-induced cell cycle arrest and the protective effect of taurine on human neuroblastoma SH-SY5Y cells. Cells were treated with or without 600
μM Al and 25 mM taurine for 24 h. (a) Cell cycle is examined by flow cytometry. (b) The quantitative data are represented as the mean ±
SEMvalues of four independent experiments.

when cells were treated with or without 25 mM taurine. Both
Al(mal)3 and taurine concentrations were in accordance with the
data reported by Chen et al. (2011) and Chou et al. (2013), respectively. The signal of cell apoptosis is presented as a fluorescent unit (FU) and is significantly increased in the Al group
(23,119 FU) compared with the control group (5,056 FU), but
the signal in the Al  taurine group was restored to 15,219 FU as
opposed to that in the Al group (Fig. 1(b)). Additionally, taurine
in the taurine group had no effect on the viability of SH-SY5Y cells
in compared with the viability of cells in the control group.
2. Effect of Taurine on Cell Cycle Arrest Induced by
Al(mal)3 Treatment Iof SH-SY5Y Cells
According to the cell viability experiment, it was investigated

whether taurine prevented cell cycle arrest in SH-SY5Y cells
on being subjected to treatment with Al(malt)3 (Fig. 2(a)). The
quantitative data show that the number of cells in the Al group
significantly increased to 49.3% in the sub G1 phase, but that in
the taurine  Al group decreased to 37.6 % (Fig. 2(b)). There is
no difference in cell distribution between the taurine group and
control group. These data demonstrated that Al(mal)3 increased
the number of sub G1 phase cells to induce cell death, but taurine
prevented cell cycle arrest when combined with Al(mal)3 treatment of SH-SY5Y cells. The respective cell ratio G1 phase cell
ratios in the control and taurine groups were similar, but those
in the Al and taurine + Al group were significantly different. This
data indicated that taurine prevented cell cycle arrest in SH-SY5Y
cells when used in combination with Al(mal)3 treatment. How-
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were treated with or without 600 μM Al and 25 mM taurine for 24 h. (a) Mitochondrial membrane potential is examined by flow cytometry. (b)
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ever, the cell ratios in S phase and G2/M phases were similar
for all the four groups.
3. Effect of Taurine on Intracellular ROS Produced after
Al(mal)3 Treatment of SH-SY5Y Cells
Using flow cytometry, the signals of intracellular ROS level
were found to be 2,658 FU; 2507 FU; 4,128 FU; and 3,173 FU for
the control group, taurine group, Al group, and taurine  Al group,
respectively (Fig. 3). The intracellular ROS level in thee Al
group was significantly increased by 55% compared with that in
the control group at 24 h (Fig. 3(b)). However, the level in the

taurine  Al group was significantly decreased by 28% compared
with that in the Al group (Fig. 3(b)). The data revealed a significant inhibition of the intracellular ROS level brought about by
taurine, indicating that taurine protected SH-SY5Y cell from damage caused by Al(mal)3 induced oxidative stress.
4. Effect of Taurine on Mitochondria Apoptosis Induced
by Al(mal)3 Treatment of SH-SY5Y Cells
MMP examination revealed that the signal of MMP in SHSY5Y cells was 10,718 FU; 10,678 FU; 4,298 FU; and 5,485 FU
for the control group, taurine group, Al group, and taurine  Al
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Fig. 6. Al-reduced neurotrophic factor gene expression and the protective effect of taurine on human neuroblastoma SH-SY5Y cells. (a) NDRG-4 (b)
BDNF, and (c) SIRT-1 genes were analyzed by quantitative real-time PCR. Cells were treated with or without 600 μM Al and 5 mM taurinefor
24 h. The quantitative data are represented as the mean ± SEM values of four independent experiments.

group, respectively (Fig. 4). The results revealed that MMP in
SH-SY5Y cells significantly decreased by 60% in the Al group
and by 48 % in the taurine  Al group compared with that in the
control group.
The protease activity of caspase 9 was examined to detect
mitochondria apoptosis (Fig. 5). The data showed that Al(malt)3
induced caspase 9 activity in SH-SY5Y cells and increased it by
36% compared with the activity in the control group (Fig. 5).
In contrast, a 26% reduction in caspase 9 expression was noted
in the taurine  Al group (Fig. 5). These data suggest that taurine
can prevent mitochondrial apoptosis in SH-SY5Y cells when
combined with Al(mal)3 treatment.

Perturbation of ER homeostasis induces cell apoptosis
through the activation of Grp78. The data demonstrated that
Al(malt)3 induced Grp78 expression in SH-SY5Y cells, but
taurine reversed Grp78 expression in SH-SY5Y cells treated with
Al(malt)3 (Fig 7(a)). The data demonstrated that the Al group and
taurine  Al group showed a significant 3.5-folds and 2.6-flods
increase in Grp78 protein levels, respectively, compared with
the Grp78 protein level in the control group (Fig. 7(b)). Moreover, no significant differences in the Grp78 protein level were
noted between the taurine and control groups.

5. Effect of Taurine on Neurotrophic Gene Expression
Induced by Al(malt)3 Treatment of SH-SY5Y Cells
To investigate whether taurine regulates neurotrophic gene expression, the NDRG-4, BDNF and SIRT-1 gene expression were
examined. The results showed that NDRG-4, BDNF and SIRT-1
gene expression levels were significantly reduced in SH-SY5Y
cells after Al(malt)3 treatment for 24 h (Fig. 6). However, taurine 
Al group exhibited significant restoration of NDRG-4, BDNF and
SIRT-1 gene expression levels compared with those in the Al group
(Fig. 6). In addition, the expression levels of all genes were not
different between the taurine group and control group.

Various metals, pesticides and phenols have been considered
as environmental pollutants (Wasi et al., 2013). In this context,
Al has been associated with global health risk in some diseases
(Hammes et al., 2012). In this context, treatment of human neuroblastoma SH-SY5Y cells with Al(malt)3 at a concentration of
600 µM for 24 h induced neuronal cell cycle arrest. Previous data
revealed that Al(malt)3 induced oxidative stress to cause mitochondrial and ER damage in SH-SY5Y cells. The intracellular
ROS levels and MMP assays revealed that treatment of SHSY5Y cells with Al(mal)3 brought about an increase in cellular
ROS levels, activation of the caspase 9 pathway, and decrease
in mitochondrial membrane potential, thereby causing mitochondrial apoptosis. Moreover, Al(mal)3 causes ER impairment
via Grp78 pathway. In facts, Al plays a major role in the patho-

6. Effect of Taurine on ER Stress Induced by Al(malt)3
Treatment of SH-SY5Y Cells

IV. DISCUSSION
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Fig. 7. The Al-induced Grp78 expression and the protect effect of taurine in SH-Y5Y cell. Cells were incubated with or without indicated concentration of
Al 600 μM and taurine 25 mM for 24 hr. (a) Grp78 expression is examined by Western blotting. (b) The quantitative data are represented as
the mean ± SEM from four independent experiments.

gentic mechanisms of neurological disease and other related disorders owing to its ability to cross-link hyperphosphorylated
proteins (Marwarha et al., 2013).
Various studies have revealed that Al was detected in amyloid fibers in senile plaque core in the brain of AD patients and
it was associated with cognitive deficiency. The generation of
ROS has been implicated in the oxidative damage of mitochondrial and ER proteins as well as in the loss of the functions of
both mitochondria and ER (Yamamot et al., 2011). A previously
published report revealed that Al(mal)3 can reduce the expression
of BDNF-induced activity-regulated cytoskeleton-associated protein (Arc) by interrupting ERK signaling in SH-SY5Y cells to
cause cognitive dysfunction (Bertholf et al., 1989). Many studies
have suggested that the loss of NTFS including BDNF, SIRT-1
and NDRG-4 impairs the hippocampus and cortex to decrease
learning capacity and memory (Bertholf et al., 1989; Broadbent
et al., 2004; Wang et al., 2009). Indeed, NDRG-4 is required for
the cell cycle progression and differentiation of neuronal cells
(Prentice et al., 2017). With respect to energy metabolism, SIRT-1
participates for neuron survival and regulates energy metabolism
by promoting mitochondrial biogenesis (Song et al., 2012). Thus,
arsenite treatment reduced the expression of NDRG-4, BDNF
and SIRT-1 in SH-SY5Y cells (Chen et al., 2011). Similarly, in
our study, the treatment of SH-SY5Y cells with Al(mal)3 decreased BDNF, SIRT-1 and NDRG-4 levels, indicating that Al
is associated with neuronal cell cycle arrest and apoptosis. Previous studies have reported that ER is also the site for amyloid
-protein generation via calcium influx for worsening neurodegenerative diseases (Kerai et al., 1999). On the other hand,
Al(mal)3 reportedly induced oxidative stress which perturbed
the ER, thereby causing the release of calcium and ER stressrelated proteins such as CHOP/GADD153 and caspase 12 to
cause neuronal cell apoptosis (Perl and Moalem, 2006). In this
study, the expression of Grp78, an ER stress-related protein,
increased after the treatment of SH-SY5Y cells with Al(mal)3.
The results supported the hypothesis that Al(mal)3 promotes
the generation of ROS to induce mitochondrial and ER stress,
thereby activating the apoptotic pathway. The results of Al toxicity in this study are similar to those reported in the above
mentioned studies.
Taurine, a nonprotein amino acid, is a natural antioxidant and
an antiatherosclerotic agent (Balkan et al., 2002). Taurine pro-

tects granular cells of the cerebellar cortex against glutamateinduced cellular toxicity by modulating intracellular calcium
homeostasis and energy metabolism (Han et al., 2013). Moreover, taurine prevents arsenite-induced cell cycle arrest in neuroblastoma cells by increasing the expression of BDNF, NDGR-4
and SIRT-1 (Chen et al., 2011). This report aroused our interest
in examining the protective effects of taurine in SH-SY5Y cells
that were subjected to Al(mal)3 treatment.

V. CONCLUSION
This study proved that taurine prevented cell cycle arrest
and reduced intracellular ROS levels to decrease mitochondria
and ER stress. Taurine also restored the expression levels of
NDGR-4, SIRT-1 and BDNF genes, which had been substantially
decreased owing to Al(mal)3 treatment. Hence, based on the results of the present study, it can be concluded that Al(malt)3
enhanced mitochondrial and ER stress and inhibited neurotrophic gene expression, and that taurine plays a regulatory role
in Al(mal)3-treated SH-SY5Y cells via NTFS
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